FSG-13124-46973
4 vaccinations
14 coded responses
48 check-ins
13 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 897 / NV
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Registered in v-safe
-
2020-12-16
Dose 1 — Pfizer-BioNTech
- 2020-12-16
- 2020-12-17
-
2020-12-18
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activitiesFree text: May not be related to the vaccine localized to hip/backMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-18
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-19
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Good · Muscle or body achesFree text: Probably not related but reporting just in caseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-21
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activitiesFree text: May not be related back/hip painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-21
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2020-12-22
Survey response — days 1–6 daily, dose 1MedDRA: Unevaluable event — Feeling: Fair · Muscle or body aches · Be unable to work, Be unable to do your normal daily activitiesFree text: May not be relatedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-22
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2020-12-24
Survey response — day 7, dose 1MedDRA: Unevaluable event — Feeling: Fair · Joint pains, Muscle or body achesFree text: May not be related to the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-30
Survey response — day 14, dose 1MedDRA: Back pain, Vertigo — Feeling: GoodFree text: Vertigo with position changes; back pain resolvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-06
Dose 2 — Pfizer-BioNTech
- 2021-01-06
-
2021-01-07
Survey response — days 1–6 daily, dose 2MedDRA: Malaise — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessFree text: General malaiseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Muscle or body achesAdult check-in
- 2021-01-09
- 2021-01-11
-
2021-01-20
Survey response — day 14, dose 2MedDRA: Musculoskeletal stiffness, Neck pain — Feeling: GoodFree text: Neck pain/stiffnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-17
Survey response — day 42, dose 2MedDRA: Back pain, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Current upper respiratory infection. Tested covid negative. Back pain currently resolved that started 3 days post first covid vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-07
- 2021-07-02
- 2021-07-07
-
2021-09-26
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-29
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-12
- 2021-10-17
- 2021-10-24
-
2021-10-31
Survey response — day 35, dose 3MedDRA: Eye inflammation — Feeling: Good · Be unable to work or attend schoolFree text: Eye inflammation.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-07
Survey response — day 42, dose 3MedDRA: Vertigo — Feeling: FairFree text: Vertigo today while sitting.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-27
- 2022-03-27
-
2022-09-26
Survey response — 12 months, dose 3MedDRA: Dyspnoea, Pre-existing disease, Tachycardia, Vertigo — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: About 1 month post COVID infection tachycardia and shortness of breath. Then that resolved and had Daily vertigo 53 days post COVID infection and current.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-26
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-27
- 2022-09-27
-
2022-10-10
Dose 4 — Pfizer-BioNTech
-
2022-10-11
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-12
-
2022-10-13
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Muscle or body achesAdult check-in
- 2022-10-14
- 2022-10-16
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-11-17
-
2022-11-23
Survey response — day 42, dose 4MedDRA: Diarrhoea — Feeling: FairFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
- 2023-01-09
-
2023-04-10
Survey response — 6 months, dose 4MedDRA: Anxiety, Post-traumatic stress disorder — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-10
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-11
- 2023-04-11
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-06 | Pfizer-BioNTech | |
| 3 | 2021-09-26 | Pfizer-BioNTech | No |
| 4 | 2022-10-10 | Pfizer-BioNTech | No |
Call center
6 call center cases
3 unsuccessful · 3 priority 2/3 (triaged and no follow up)
1 wait over 3 months for a first call
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): May not be related to the vaccine localized to hip/back
Systemic reaction (other): Probably not related but reporting just in case
Systemic reaction (other): May not be related back/hip pain
Systemic reaction (other): May not be related
Release 1 — day 7, dose 1
Systemic reaction (other): May not be related to the vaccine
Release 1 — day 14, dose 1
Symptoms: Vertigo with position changes; back pain resolving
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): General malaise
Release 2 — day 14, dose 2
Symptoms: Neck pain/stiffness
Release 4 — day 42, dose 2
Symptoms: Current upper respiratory infection. Tested covid negative. Back pain currently resolved that started 3 days post first covid vaccine.
Release 10 — day 35, dose 3
Symptoms: Eye inflammation.
Release 10 — day 42, dose 3
Symptoms: Vertigo today while sitting.
Release 12 — 12 months, dose 3
Symptoms: About 1 month post COVID infection tachycardia and shortness of breath. Then that resolved and had Daily vertigo 53 days post COVID infection and current.
Release 12 — day 42, dose 4
Symptoms: Diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | · | · | ✓ |
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Eye inflammation | · | · | ✓ |
| SD | Musculoskeletal stiffness | ✓ | ✓ | ✓ |
| SD | Neck pain | ✓ | ✓ | ✓ |
| SD | Post-traumatic stress disorder | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Tachycardia | · | · | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SD | Vertigo | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ○ | ○ | ○ |
| SRO | Back pain | ○ | ○ | ○ |
| SRO | Malaise | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release